Suppr超能文献

通过外显子组测序鉴定 ATP1A3 突变是日本患儿交替性偏瘫的病因。

Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients.

机构信息

Department of Pediatrics, School of Medicine, Fukuoka University, Fukuoka, Japan.

出版信息

PLoS One. 2013;8(2):e56120. doi: 10.1371/journal.pone.0056120. Epub 2013 Feb 8.

Abstract

BACKGROUND

Alternating hemiplegia of childhood (AHC) is a rare disorder characterized by transient repeated attacks of paresis and cognitive impairment. Recent studies from the U.S. and Europe have described ATP1A3 mutations in AHC. However, the genotype-phenotype relationship remains unclear. The purpose of this study was to identify the genetic abnormality in a Japanese cohort of AHC using exome analysis.

PRINCIPAL FINDINGS

A total of 712,558 genetic single nucleotide variations in 8 patients with sporadic AHC were found. After a series of exclusions, mutations of three genes were regarded as candidate causes of AHC. Each patient harbored a heterozygous missense mutation of ATP1A3, which included G755C, E815K, C927Y and D801N. All mutations were at highly conserved amino acid residues and deduced to affect ATPase activity of the corresponding ATP pump, the product of ATP1A3. They were de novo mutations and not identified in 96 healthy volunteers. Using Sanger sequencing, E815K was found in two other sporadic cases of AHC. In this study, E815K was found in 5 of 10 patients (50%), a prevalence higher than that reported in two recent studies [19 of 82 (23%) and 7 of 24 (29%)]. Furthermore, the clinical data of the affected individuals indicated that E815K resulted in a severer phenotype compared with other ATP1A3 mutations.

INTERPRETATION

Heterozygous de novo mutations of ATP1A3 were identified in all Japanese patients with AHC examined in this study, confirming that ATP1A3 mutation is the cause of AHC.

摘要

背景

儿童交替性偏瘫(AHC)是一种罕见的疾病,其特征是短暂的反复发作性瘫痪和认知障碍。最近来自美国和欧洲的研究描述了 AHC 中的 ATP1A3 突变。然而,基因型-表型关系仍不清楚。本研究的目的是使用外显子组分析鉴定日本 AHC 患者的遗传异常。

主要发现

在 8 例散发性 AHC 患者中发现了总计 712558 个遗传单核苷酸变异。经过一系列排除,三个基因的突变被认为是 AHC 的候选原因。每位患者均携带 ATP1A3 的杂合错义突变,包括 G755C、E815K、C927Y 和 D801N。所有突变均位于高度保守的氨基酸残基上,并推断会影响相应 ATP 泵的 ATP 酶活性,即 ATP1A3 的产物。它们是新生突变,在 96 名健康志愿者中未发现。使用 Sanger 测序,在另外两例散发性 AHC 病例中发现了 E815K。在本研究中,E815K 见于 10 例患者中的 5 例(50%),患病率高于最近两项研究的报告[82 例中的 19 例(23%)和 24 例中的 7 例(29%)]。此外,受影响个体的临床数据表明,与其他 ATP1A3 突变相比,E815K 导致更严重的表型。

解释

在本研究中检查的所有日本 AHC 患者均发现 ATP1A3 的杂合新生突变,证实 ATP1A3 突变是 AHC 的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0934/3568031/b996368130e1/pone.0056120.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验